| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |